SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-07-060257
Filing Date
2007-08-08
Accepted
2007-08-08 16:37:35
Documents
10
Period of Report
2007-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a07-18711_110q.htm 10-Q 813047
2 EX-4.2 a07-18711_1ex4d2.htm EX-4.2 310294
3 EX-10.31 a07-18711_1ex10d31.htm EX-10.31 55718
4 EX-10.39 a07-18711_1ex10d39.htm EX-10.39 53264
5 EX-10.40 a07-18711_1ex10d40.htm EX-10.40 48538
6 EX-10.41 a07-18711_1ex10d41.htm EX-10.41 45943
7 EX-10.42 a07-18711_1ex10d42.htm EX-10.42 66870
8 EX-31.1 a07-18711_1ex31d1.htm EX-31.1 9928
9 EX-31.2 a07-18711_1ex31d2.htm EX-31.2 10435
10 EX-32 a07-18711_1ex32.htm EX-32 8725
  Complete submission text file 0001104659-07-060257.txt   1424248
Mailing Address 901 GATEWAY BLVD S. SAN FRANCISCO CA 94080
Business Address 901 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080 6508086000
THERAVANCE INC (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30319 | Film No.: 071036129
SIC: 2834 Pharmaceutical Preparations